Press "Enter" to skip to content

J&J shares nosedive on report it knew of asbestos in Baby Powder

The decline in shares erased about $40 billion from the company’s market capitalisation, with investors worrying about the impact of the report as it faces thousands of talc-related lawsuits.

Original source: https://health.economictimes.indiatimes.com/news/pharma/jj-shares-nosedive-on-report-it-knew-of-asbestos-in-baby-powder/67101252?utm_source=RSS&utm_medium=ETRSS

Also Read:   France's Sanofi to buy US group Principia Biopharma for $3.68 bln